Molecular Research in Genitourinary Oncology
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 March 2026
Special Issue Editors
Interests: genitourinary oncology; prostate cancer; renal cell cancer; molecular biomarkers; targeted therapy
Interests: laparoscopic surgery; urology; robotic surgery; urogenital cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Genitourinary oncology encompasses cancers of the prostate, bladder, kidney, testis, and penis, where molecular research is driving transformative advances in diagnosis, prognosis, and therapy. This Special Issue will highlight cutting-edge studies that elucidate tumor biology, immune interactions, and microenvironmental influences that may affect genitourinary malignancies. Emphasis areas include genomic and epigenomic profiling to identify driver mutations, actionable targets, and predictive biomarkers. Our Special Issue is interested in novel translational research exploring new targeted agents, immunotherapies, combination regimens, and mechanisms of resistance, including the development of liquid biopsies (circulating tumor DNA, exosomes) and advanced imaging biomarkers for early detection and disease monitoring. By assembling multidisciplinary perspectives, the Special Issue aims to accelerate precision medicine in genitourinary cancers, foster biologically informed clinical trials, and chart future directions for improving patient outcomes.
Dr. Ilias Giannakodimos
Dr. Ioannis Zachos
Dr. Vassilios P. Tzortzis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genitourinary oncology
- molecular biomarkers
- genomics and epigenomics
- tumor microenvironment
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
